Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib + Diacerein vs Meloxicam + Diacerein in Knee/Hip Osteoarthritis
NCT07549386Phase 3Completed
- Sponsor
- Laboratorios Liomont
- Start
- May 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoricoxib in osteoarthritis (OA), sponsored by Laboratorios Liomont. Started May 2024; status: completed.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07549386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549386.